Lv2
170 积分 2024-11-04 加入
Timing of nivolumab with neoadjuvant carboplatin and paclitaxel for early triple-negative breast cancer (BCT1902/IBCSG 61–20; Neo-N): a non-comparative, open-label, randomised, phase 2 trial
2个月前
已完结
Metronomic capecitabine as extended adjuvant chemotherapy for early triple-negative breast cancer (SYSUCC-001): updated 10-year outcomes and post-hoc exploratory biomarker analysis from a randomised, phase 3 trial
2个月前
已完结
The occurrence, causes and outcome of delirium in advanced cancer patients: a prospective study
4个月前
已关闭
Overall Survival with Ribociclib plus Letrozole in Advanced Breast Cancer
7个月前
已完结
De-escalated neoadjuvant weekly nab-paclitaxel with trastuzumab and pertuzumab versus docetaxel, carboplatin, trastuzumab, and pertuzumab in patients with HER2-positive early breast cancer (HELEN-006): a multicentre, randomised, phase 3 trial
8个月前
已完结
皖公网安备34019202002308
